ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: ABI-007|DRUG: Bevacizumab
Sponsor: Celgene